Sonoma Pharmaceuticals (SNOA) Capital Leases (2017 - 2018)
Sonoma Pharmaceuticals (SNOA) posted quarterly Capital Leases of $62000.0 for Q3 2018, down 71.69% year-over-year from $219000.0 in Q3 2017, and down 40.38% quarter-over-quarter from $104000.0 in Q2 2018.
Sonoma Pharmaceuticals (SNOA) Capital Leases (2017 - 2018) Analysis & Trends
Sonoma Pharmaceuticals' Capital Leases history runs 2 years deep, the most recent figure standing at $62000.0 for Q3 2018.
- In Q3 2018, Capital Leases fell 71.69% year-over-year to $62000.0; the TTM figure through Sep 2018 stood at $62000.0 (down 71.69% YoY), while the FY2018 annual figure was $144000.0, down 14.29% from the prior year.
- Capital Leases for Q3 2018 stood at $62000.0, down from $104000.0 in the prior quarter.
- The five-year high for Capital Leases was $252000.0 in Q2 2017, with the low at $62000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.15 Mn | -184,359.87 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 62,000.00 |
| Jun 30, 2018 | 104,000.00 |
| Mar 31, 2018 | 144,000.00 |
| Dec 31, 2017 | 179,000.00 |
| Sep 30, 2017 | 219,000.00 |
| Jun 30, 2017 | 252,000.00 |
| Mar 31, 2017 | 168,000.00 |